Read full article on publisher's websiteSAFE-BioPharma Association, the non-profit collaboration that developed and manages the global SAFE-BioPharma® digital identity and digital signature standard, has elected Greg Koski, PhD, MD to its Board of Directors. Dr. Koski is Co-Founder & President/CEO, Alliance for Clinical Research Excellence and Safety (ACRES), Boston, MA. ACRES is a private, non-profit global network for clinical research based on standardized policies and procedures, regulatory simplification, professionalism and information technology.
The SAFE-BioPharma standard is a strategic initiative of the life sciences industry to facilitate secure, trusted and fully electronic business and regulatory processes. The standard is used throughout the biopharmaceutical and healthcare industries to manage digital identity trust and to apply legally binding digital signatures to electronic documents. The association’s members include most of the world’s largest biopharmaceutical companies.
